The U.S. Food and Drug Administration (FDA) has approved Revuforj (revumenib), which is a menin inhibitor, for the treatment ...
Panelists discuss how current NCCN guidelines emphasize the importance of treating AML at experienced centers with proper ...
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the ...
National Comprehensive Cancer Network overhauls two major resources to help cancer care providers and other stakeholders stay current on cutting edge research into genetic/familial high-risk ...
Invivyd, Inc. has announced that its investigational monoclonal antibody, PEMGARDA® (pemivibart), has been added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for ...
The new interactive guideline tool represents a major format change for gold-standard NCCN Guidelines. "This is truly the future of cancer treatment guidance," said Crystal S. Denlinger, MD, Chief ...
Puma Biotechnology (PBYI) announced that the National Comprehensive Cancer Network, or NCCN, Clinical Practice Guidelines in Oncology for Cervical Cancer were updated to include an addition involving ...
Furthermore, PET scans have a false positive rate, where 50% of positive scans or more are not due to residual lymphoma,” said Mark Roschewski, MD, Senior Clinician and the Clinical Director of the ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...
GlobalData on MSN
GSK’s Blenrep gains FDA approval for myeloma treatment
The approval is based on data from a Phase III trial evaluating patients who had received two or more previous treatments.
HOLLYWOOD, Florida ― Now in their 20th year, the National Comprehensive Cancer Network (NCCN) guidelines have greatly evolved from early efforts and continue to add new wrinkles, according to ...
Medscape Hematology-Oncology is pleased to present the latest update to the NCCN Clinical Practice Guidelines in Oncology™ Prostate Cancer, released in December 2009. The updated NCCN Guideline, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback